LIFEVANTAGE CORP

LFVN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $182.6M $228.5M $200.2M $213.4M $206.4M $220.2M $232.9M $226.0M
Cost of Revenue $41.0M $44.9M $41.4M $43.4M $38.1M $38.2M $38.0M $38.0M
Gross Profit $141.6M $183.7M $158.7M $170.0M $168.3M $182.0M $195.0M $188.0M
Gross Margin 77.6% 80.4% 79.3% 79.7% 81.5% 82.7% 83.7% 83.2%
Operating Expenses
Research & Development $1.0M $1.4M $700.0K $600.0K $700.0K $700.0K $900.0K $1.1M
SG&A Expense $58.4M $69.2M $68.5M $71.1M $63.4M $60.8M $67.9M $69.6M
Operating Income $6.1M $12.2M $4.3M $4.3M $7.6M $17.6M $15.5M $9.8M
Operating Margin 3.3% 5.3% 2.2% 2.0% 3.7% 8.0% 6.6% 4.3%
Interest Expense $-430.0K $-198.0K $10.0K $17.0K $120.0K $323.0K
Pretax Income $6.1M $12.2M $4.4M $4.0M $4.7M $17.2M $14.7M $9.2M
Income Tax Expense $994.0K $2.4M $1.4M $1.5M $1.6M $4.3M $3.1M $1.8M
Net Income $5.1M $9.8M $2.9M $2.5M $3.1M $12.9M $11.5M $7.4M
Net Margin 2.8% 4.3% 1.5% 1.2% 1.5% 5.9% 5.0% 3.3%
EPS (Basic) $0.40 $0.80 $0.24 $0.20 $0.24 $0.92 $0.82 $0.53
EPS (Diluted) $0.40 $0.75 $0.23 $0.20 $0.24 $0.90 $0.79 $0.50
Shares Outstanding (Basic) 12.5M 12.3M 12.5M 12.6M 12.9M 14.1M 14.1M 14.1M
Shares Outstanding (Diluted) 12.7M 13.0M 13.0M 12.6M 13.1M 14.3M 14.6M 15.0M
Dividends Per Share $0.19 $0.17 $0.55 $0.13 $0.03
← Newer Page 1 of 2 Older →